"Adrenergic beta-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate beta-adrenergic receptors.
| Descriptor ID |
D000318
|
| MeSH Number(s) |
D27.505.519.625.050.100.200 D27.505.696.577.050.100.200
|
| Concept/Terms |
Adrenergic beta-Agonists- Adrenergic beta-Agonists
- Adrenergic beta Agonists
- beta-Agonists, Adrenergic
- Adrenergic beta-Receptor Agonist
- Adrenergic beta Receptor Agonist
- Agonist, Adrenergic beta-Receptor
- beta-Receptor Agonist, Adrenergic
- Adrenergic beta-Receptor Agonists
- Adrenergic beta Receptor Agonists
- Agonists, Adrenergic beta-Receptor
- beta-Receptor Agonists, Adrenergic
- beta-Adrenergic Agonist
- Agonist, beta-Adrenergic
- beta Adrenergic Agonist
- Receptors Agonists, Adrenergic beta
- beta-Adrenergic Receptor Agonist
- Agonist, beta-Adrenergic Receptor
- Receptor Agonist, beta-Adrenergic
- beta Adrenergic Receptor Agonist
- beta-Adrenergic Receptor Agonists
- Agonists, beta-Adrenergic Receptor
- beta Adrenergic Receptor Agonists
- Betamimetics
- Receptor Agonists, beta-Adrenergic
- Receptor Agonists, beta Adrenergic
- Adrenergic beta-Agonist
- Adrenergic beta Agonist
- beta-Agonist, Adrenergic
- beta-Adrenergic Agonists
- Agonists, beta-Adrenergic
- beta Adrenergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Agonists".
This graph shows the total number of publications written about "Adrenergic beta-Agonists" by people in this website by year, and whether "Adrenergic beta-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 2 | 4 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 2 | 3 | 5 |
| 2005 | 0 | 1 | 1 |
| 2006 | 3 | 2 | 5 |
| 2007 | 4 | 3 | 7 |
| 2008 | 1 | 3 | 4 |
| 2009 | 1 | 1 | 2 |
| 2010 | 3 | 0 | 3 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 2 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic beta-Agonists" by people in Profiles.
-
Response of the periodontal tissues to ?-adrenergic stimulation. Life Sci. 2021 Sep 15; 281:119776.
-
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respir Med. 2021 01; 176:106278.
-
Skeletal muscle microvasculature response to ?-adrenergic stimuli is diminished with cardiac surgery. Surgery. 2020 02; 167(2):493-498.
-
Protein Phosphatase 2A Regulates Cardiac Na+ Channels. Circ Res. 2019 03; 124(5):737-746.
-
Reducing pediatric asthma hospital length of stay through evidence-based quality improvement and deployment of computerized provider order entry. J Asthma. 2020 02; 57(2):123-135.
-
Phosphorylation of the ryanodine receptor 2 at serine 2030 is required for a complete ?-adrenergic response. J Gen Physiol. 2019 02 04; 151(2):131-145.
-
Extracorporeal Cardiopulmonary Resuscitation in the Pediatric Cardiac Population: In Search of a Standard of Care. Pediatr Crit Care Med. 2018 02; 19(2):125-130.
-
Evolutionary action and structural basis of the allosteric switch controlling ?2AR functional selectivity. Nat Commun. 2017 12 18; 8(1):2169.
-
?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem. 2017 06 16; 292(24):9967-9974.
-
Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. Oncogene. 2017 03; 36(11):1525-1536.